Discovery and validation of a personalized risk predictor for incident tuberculosis in low transmission settings

Journal: Nature Medicine

Published: 2020-10-19

DOI: 10.1038/s41591-020-1076-0

Affiliations: 40

Authors: 37

Go to article
Institutions Share
UCL, United Kingdom (UK) 0.30
BC Centre for Disease Control (BCCDC), PHSA, Canada 0.08
German Center for Infection Research (DZIF), Germany 0.06
University of Leicester, United Kingdom (UK) 0.05
KNCV Tuberculosis Foundation, Netherlands 0.03
Research Institute of Tuberculosis, JATA, Japan 0.03
Stellenbosch University (SU), South Africa 0.03
University of Barcelona (UB), Spain 0.03
Helmholtz Centre for Infection Research (HZI), Germany 0.03
The State Serum Institute (SSI), Denmark 0.03
Danube Hospital Vienna, Austria 0.03
Philipps University of Marburg (Uni Marburg), Germany 0.03
Federal State of Hessen, Germany 0.03
Burnet Institute, Australia 0.02
Alfred Health, Australia 0.02
Monash University, Australia 0.02
University of Cape Town (UCT), South Africa 0.01
Swiss Lung Association, Switzerland 0.01
Vall d'Hebron University Hospital (HUVH), ICS, Spain 0.01
University of Sassari (UniSS), Italy 0.01
Serveis Clínics, Spain 0.01
Saarland University (Saar-Uni), Germany 0.01
University Medical Center Schleswig-Holstein - Campus Kiel (UKSH Kiel), Germany 0.01
Airway Research Center North (ARCN), Germany 0.01
Bond University, Australia 0.01
Liverpool Hospital, Australia 0.01
Royal Free London NHS Foundation Trust, United Kingdom (UK) 0.01
Amsterdam Institute for Global Health and Development (AIGHD), Netherlands 0.01
Amsterdam UMC, Netherlands 0.01
Institute for Health Science Research Germans Trias i Pujol (IGTP), HUGTP ICS, Spain 0.01
Biomedical Research Networking Centers (CIBER), Spain 0.01
Autonomous University of Barcelona (UAB), Spain 0.01
Karolinska Institute (KI), Sweden 0.01
Leibniz Research Center Borstel - Center for Medicine and Biosciences (FZB), Germany 0.01